Argipressin(4¡ª8) Upregulate CTP: Phosphocholine Cytidylyltransferase in Rat Hippocampal Neurons

XU Kan-Yan, XIONG Ying, DU Yu-Cang*
( Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China )

Abstract    In order to study the effect of argipressin(4¡ª8)(AVP4¡ª8) on the mRNA level and activity of cytidine triphosphate: phosphocholine cytidylyltransferase(CCT) in rat hippocampal neurons, and elucidate it's possible mechanism. Rat hippocampal neurons treated with AVP4¡ª8 or actinomycin D were incubated with different time periods. The mRNA level of CCT was detected using RT-PCR plus Southern blot, CCT activity was determined by measuring the rate of incorporation of £Û14C£Ý- phosphocholine into cytidine diphosphate-choline(CDP-choline). It was found that AVP4¡ª8 could upregulate the CCT mRNA in rat hippocampal neurons. ZDC(C)PR, the antagonist of AVP4¡ª8, could greatly inhibit this upregulation. Using actinomycin D to inhibite the eucaryotic transcription, it was found that the halflife of CCT mRNA could be prolonged by coincubation with AVP4¡ª8. Meanwhile, AVP4¡ª8 could also increase CCT activity in rat hippocampal neurons. These results demonstrated that AVP4¡ª8 upregulated CCT mRNA level and its activity through stabilizing the CCT mRNA in rat hippocampal neurons.
Key words    argipressin; CTP: phosphocholine cytidylyltransferase; hippocampus; phosphatidylcholine; actinomycin D

*Corresponding author: Tel, 86-21-64374430; Fax, 86-21-64338357£» e-mail, duyc@ sunm.shnc.ac.cn